Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
CN |
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
13.9B CNY | 8.5 | ||
CH |
Alcon AG
SIX:ALC
|
39.8B CHF | 5 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 8.3 | ||
DK |
Coloplast A/S
CSE:COLO B
|
184.5B DKK | 8 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19.2B USD | 4.7 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.7B USD | 5.8 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
59.5B CNY | 13.8 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 58.8 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 1.8 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | 232.5 | |
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF | 10.6 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.